On Invalid Date, Acutus Medical (NASDAQ: AFIB) reported Q4 2023 earnings per share (EPS) of -$1.16, up 318.87% year over year. Total Acutus Medical earnings for the quarter were -$33.77 million. In the same quarter last year, Acutus Medical's earnings per share (EPS) was $0.53.
As of Q2 2024, Acutus Medical's earnings has grown year over year. Acutus Medical's earnings in the past year totalled -$81.66 million.
What is AFIB's earnings date?
Acutus Medical's earnings date is Invalid Date. Add AFIB to your watchlist to be reminded of AFIB's next earnings announcement.
What was AFIB's revenue last quarter?
On Invalid Date, Acutus Medical (NASDAQ: AFIB) reported Q4 2023 revenue of -$7.53 million up 10.01% year over year. In the same quarter last year, Acutus Medical's revenue was -$8.37 million.
What was AFIB's revenue growth in the past year?
As of Q2 2024, Acutus Medical's revenue has grown 136.36% year over year. This is 126.89 percentage points higher than the US Medical Devices industry revenue growth rate of 9.47%. Acutus Medical's revenue in the past year totalled $7.16 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.